Market Closed

CTXR
Citius Pharmaceuticals
$ 0.5351
0.51%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Citius Pharmaceuticals News

Latest Citius Pharmaceuticals Stock News & CTXR Headlines

Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
19 days ago | prnewswire.com
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
a month ago | prnewswire.com
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Stock Now Rated “Hold” by Wall Street Brokerages
a month ago | defenseworld.net
Citius Pharmaceuticals (NASDAQ:CTXR) versus Tarsus Pharmaceuticals (NASDAQ:TARS) Financial Analysis
2 months ago | defenseworld.net
Brokerages Set Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) PT at $5.00
2 months ago | defenseworld.net
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
3 months ago | prnewswire.com
Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
3 months ago | prnewswire.com
Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment
3 months ago | prnewswire.com
Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption
4 months ago | prnewswire.com
Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies
5 months ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CTXR
Citius Pharmaceuticals
$ 0.5351
0.51%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago